Literature DB >> 32710436

Serum Klotho levels in primary hyperparathyroidism patients before and after parathyroidectomy.

Chi Su1, Lingqiong Meng2, Stanley Z Trooskin3, Sue A Shapses2, Yuling He1, Aseel Al-Dayyeni1, Xiangbing Wang4.   

Abstract

PURPOSE: To investigate Klotho level and its association with biochemical indices of primary hyperparathyroidism (PHPT).
METHODS: Fifty PHPT patients and fifty-two age- and body mass index-(BMI) matched healthy control subjects were recruited. In addition, twenty-five PHPT patients underwent parathyroidectomy (PTX) and had 4-month follow-up visits. Intact parathyroid hormone (iPTH), 25-hydroxyvitamin D [25(OH)D], calcium, albumin, corrected calcium, and Klotho levels were determined.
RESULTS: There was no significant difference in age and BMI between PHPT subjects and controls (p > 0.05). PHPT patients had Klotho levels (15.4 ± 1.2 ng/mL) about 23% higher compared with those of the controls (11.9 ± 0.8 ng/mL), but this difference was not significant (p = 0.063). However, postmenopausal PHPT patients had 45% higher Klotho levels (17.6 ± 1.5 ng/ml) compared with postmenopausal controls (12.1 ± 0.9 ng/mL, p = 0.008). For postmenopausal subjects, Klotho levels had positive correlation with levels of iPTH (r = 0.25, p = 0.026) and corrected calcium (r = 0.34, p = 0.003), but negative correlation with 25(OH)D (r = -0.23, p = 0.042). After PTX, levels of iPTH and corrected calcium decreased and 25(OH)D levels increased to normal range (p < 0.001). However, there was no significant change in Klotho levels after a 4-month follow-up.
CONCLUSIONS: Serum Klotho levels are higher in postmenopausal PHPT patients than in healthy postmenopausal control subjects. The etiology of elevated Klotho level and its clinical significance requires further investigation.

Entities:  

Keywords:  Hyperparathyroidism; Klotho; Parathyroid hormone; Parathyroidectomy; Post-menopausal

Mesh:

Substances:

Year:  2020        PMID: 32710436     DOI: 10.1007/s12020-020-02427-w

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  20 in total

Review 1.  Klotho in health and disease.

Authors:  Makoto Kuro-o
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

Review 2.  Renal impairment as a surgical indication in primary hyperparathyroidism: do the data support this recommendation?

Authors:  Chase D Hendrickson; Daniel J Castro Pereira; Richard J Comi
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

3.  Is osteocyte Klotho bad for bone health?

Authors:  Rosa M A Moysés; Adriana Dusso
Journal:  Kidney Int       Date:  2017-09       Impact factor: 10.612

Review 4.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

5.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

6.  Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

Authors:  Jian Q Feng; Leanne M Ward; Shiguang Liu; Yongbo Lu; Yixia Xie; Baozhi Yuan; Xijie Yu; Frank Rauch; Siobhan I Davis; Shubin Zhang; Hector Rios; Marc K Drezner; L Darryl Quarles; Lynda F Bonewald; Kenneth E White
Journal:  Nat Genet       Date:  2006-10-08       Impact factor: 38.330

7.  Cardiac structure and diastolic function in mild primary hyperparathyroidism.

Authors:  M D Walker; J B Fleischer; M R Di Tullio; S Homma; T Rundek; E M Stein; C Zhang; T Taggart; D J McMahon; S J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2010-03-12       Impact factor: 5.958

8.  1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.

Authors:  Thomas K Barthel; Douglas R Mathern; G Kerr Whitfield; Carol A Haussler; H Andrew Hopper; Jui-Cheng Hsieh; Stephanie A Slater; Grace Hsieh; Magdalena Kaczmarska; Peter W Jurutka; Olga I Kolek; Fayez K Ghishan; Mark R Haussler
Journal:  J Steroid Biochem Mol Biol       Date:  2007-02-12       Impact factor: 4.292

Review 9.  Changes in expression of klotho affect physiological processes, diseases, and cancer.

Authors:  Nguyen Thi Xuan; Nong Van Hai
Journal:  Iran J Basic Med Sci       Date:  2018-01       Impact factor: 2.699

10.  Comparison of Initial Clinical Presentations between Primary Hyperparathyroidism Patients from New Brunswick and Changsha.

Authors:  Lingqiong Meng; Shuying Liu; Aseel Al-Dayyeni; Zhifeng Sheng; Zhiguang Zhou; Xiangbing Wang
Journal:  Int J Endocrinol       Date:  2018-09-18       Impact factor: 3.257

View more
  1 in total

1.  Total and free vitamin D metabolites in patients with primary hyperparathyroidism.

Authors:  L Meng; C Su; S A Shapses; X Wang
Journal:  J Endocrinol Invest       Date:  2021-07-19       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.